364 related articles for article (PubMed ID: 16434701)
1. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.
Saramäki A; Banwell CM; Campbell MJ; Carlberg C
Nucleic Acids Res; 2006; 34(2):543-54. PubMed ID: 16434701
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter.
Sinkkonen L; Malinen M; Saavalainen K; Väisänen S; Carlberg C
Nucleic Acids Res; 2005; 33(8):2440-51. PubMed ID: 15863722
[TBL] [Abstract][Full Text] [Related]
3. The impact of chromatin organization of vitamin D target genes.
Carlberg C; Dunlop TW
Anticancer Res; 2006; 26(4A):2637-45. PubMed ID: 16886674
[TBL] [Abstract][Full Text] [Related]
4. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).
Muto A; Kizaki M; Yamato K; Kawai Y; Kamata-Matsushita M; Ueno H; Ohguchi M; Nishihara T; Koeffler HP; Ikeda Y
Blood; 1999 Apr; 93(7):2225-33. PubMed ID: 10090931
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D
Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
[TBL] [Abstract][Full Text] [Related]
9. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
10. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
12. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
[TBL] [Abstract][Full Text] [Related]
14. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3.
Malinen M; Saramäki A; Ropponen A; Degenhardt T; Väisänen S; Carlberg C
Nucleic Acids Res; 2008 Jan; 36(1):121-32. PubMed ID: 17999998
[TBL] [Abstract][Full Text] [Related]
15. Selective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene.
Turunen MM; Dunlop TW; Carlberg C; Väisänen S
Nucleic Acids Res; 2007; 35(8):2734-47. PubMed ID: 17426122
[TBL] [Abstract][Full Text] [Related]
16. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
[TBL] [Abstract][Full Text] [Related]
17. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells.
Akutsu N; Lin R; Bastien Y; Bestawros A; Enepekides DJ; Black MJ; White JH
Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613
[TBL] [Abstract][Full Text] [Related]
18. Controlling the chromatin organization of vitamin D target genes by multiple vitamin D receptor binding sites.
Carlberg C; Dunlop TW; Saramäki A; Sinkkonen L; Matilainen M; Väisänen S
J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):338-43. PubMed ID: 17234401
[TBL] [Abstract][Full Text] [Related]
19. Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3.
Väisänen S; Dunlop TW; Sinkkonen L; Frank C; Carlberg C
J Mol Biol; 2005 Jul; 350(1):65-77. PubMed ID: 15919092
[TBL] [Abstract][Full Text] [Related]
20. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1).
Song CS; Echchgadda I; Seo YK; Oh T; Kim S; Kim SA; Cho S; Shi L; Chatterjee B
Mol Endocrinol; 2006 Apr; 20(4):795-808. PubMed ID: 16357103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
